Vivani Medical (NASDAQ:VANI - Get Free Report)'s stock had its "buy" rating reissued by HC Wainwright in a research report issued on Wednesday,Benzinga reports. They presently have a $4.00 price target on the stock. HC Wainwright's price target suggests a potential upside of 292.16% from the stock's current price.
Vivani Medical Stock Performance
Shares of VANI traded down $0.04 during midday trading on Wednesday, hitting $1.02. 94,154 shares of the stock traded hands, compared to its average volume of 168,283. Vivani Medical has a 1-year low of $0.91 and a 1-year high of $2.09. The business's 50 day moving average price is $1.08 and its two-hundred day moving average price is $1.19. The firm has a market capitalization of $60.42 million, a PE ratio of -2.27 and a beta of 2.76.
Vivani Medical (NASDAQ:VANI - Get Free Report) last released its quarterly earnings results on Monday, March 31st. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.01). As a group, equities research analysts forecast that Vivani Medical will post -0.41 EPS for the current fiscal year.
Insider Activity at Vivani Medical
In related news, Director Gregg Williams acquired 44,400 shares of the stock in a transaction that occurred on Monday, April 7th. The shares were acquired at an average price of $0.99 per share, for a total transaction of $43,956.00. Following the completion of the purchase, the director now directly owns 4,799,200 shares of the company's stock, valued at $4,751,208. The trade was a 0.93 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders purchased 106,240 shares of company stock worth $106,060 in the last 90 days. Corporate insiders own 44.30% of the company's stock.
Hedge Funds Weigh In On Vivani Medical
Several hedge funds have recently modified their holdings of VANI. Geode Capital Management LLC lifted its holdings in Vivani Medical by 4.6% in the 3rd quarter. Geode Capital Management LLC now owns 342,891 shares of the company's stock valued at $401,000 after acquiring an additional 15,008 shares during the last quarter. Northern Trust Corp boosted its holdings in Vivani Medical by 19.1% during the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company's stock worth $83,000 after buying an additional 11,540 shares in the last quarter. Jane Street Group LLC acquired a new position in Vivani Medical in the fourth quarter worth approximately $66,000. Finally, Wealthedge Investment Advisors LLC bought a new stake in shares of Vivani Medical during the 4th quarter worth $43,000. 6.78% of the stock is currently owned by institutional investors and hedge funds.
About Vivani Medical
(
Get Free Report)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Articles
Before you consider Vivani Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivani Medical wasn't on the list.
While Vivani Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
